CIABATTONI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 4.092
EU - Europa 3.453
AS - Asia 2.356
SA - Sud America 110
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 6
OC - Oceania 3
Totale 10.029
Nazione #
US - Stati Uniti d'America 4.072
SG - Singapore 815
UA - Ucraina 807
CN - Cina 712
TR - Turchia 634
IE - Irlanda 605
GB - Regno Unito 525
SE - Svezia 496
FR - Francia 314
DE - Germania 243
FI - Finlandia 177
IN - India 145
IT - Italia 124
RU - Federazione Russa 124
BR - Brasile 97
CA - Canada 15
HK - Hong Kong 14
CZ - Repubblica Ceca 11
EU - Europa 9
PL - Polonia 8
AR - Argentina 6
IL - Israele 6
IR - Iran 6
MX - Messico 5
AT - Austria 3
AU - Australia 3
BE - Belgio 3
EG - Egitto 3
NL - Olanda 3
TW - Taiwan 3
VN - Vietnam 3
BD - Bangladesh 2
EC - Ecuador 2
IQ - Iraq 2
LB - Libano 2
LT - Lituania 2
PK - Pakistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
DZ - Algeria 1
ES - Italia 1
GE - Georgia 1
ID - Indonesia 1
IM - Isola di Man 1
JO - Giordania 1
JP - Giappone 1
KG - Kirghizistan 1
KR - Corea 1
LI - Liechtenstein 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
UY - Uruguay 1
ZA - Sudafrica 1
Totale 10.029
Città #
Jacksonville 857
Chandler 740
Singapore 604
Dublin 602
Southend 454
Princeton 314
Izmir 311
Nanjing 202
Wilmington 184
Santa Clara 152
Cambridge 143
Ashburn 132
Dearborn 132
Beijing 123
The Dalles 76
Nanchang 74
Woodbridge 68
Ann Arbor 60
Boardman 58
Shenyang 45
Altamura 40
New York 38
Hebei 34
Kunming 34
Tianjin 34
Grevenbroich 33
Washington 32
Los Angeles 31
Helsinki 30
Changsha 28
Jiaxing 28
Munich 24
Norwalk 24
Moscow 23
Hangzhou 17
Houston 16
Orange 15
Chieti 14
Falls Church 14
Hong Kong 14
Augusta 13
Jinan 13
San Mateo 13
Brno 10
Seattle 9
Changchun 8
Lanzhou 8
Zhengzhou 8
Auburn Hills 7
Leawood 7
São Paulo 7
Brooklyn 6
Ningbo 5
Pune 5
Taiyuan 5
Toronto 5
Turku 5
Hackney 4
London 4
Mountain View 4
Perugia 4
Shanghai 4
Sulmona 4
Tappahannock 4
Warsaw 4
Anzola Dell'emilia 3
Atlanta 3
Brasília 3
Brussels 3
Fuzhou 3
Hefei 3
Kraków 3
Montreal 3
Ottawa 3
Pescara 3
Rio de Janeiro 3
Rome 3
Roseto degli Abruzzi 3
Taipei 3
Taizhou 3
Walnut 3
Boston 2
Cairo 2
Campo Grande 2
Cedar Knolls 2
Chaoyang 2
Chicago 2
Dong Ket 2
Frankfurt am Main 2
Hillsborough 2
Ibicoara 2
Juiz de Fora 2
Kocaeli 2
Lahore 2
Mexico City 2
Milan 2
Mumbai 2
Naples 2
Niterói 2
Pelotas 2
Totale 6.106
Nome #
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 129
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 120
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 119
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 108
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 107
Amylin inhibits hypothalamic dopamine release. 106
Determinants of platelet activation in hypertensives with microalbuminuria. 104
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation 103
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 102
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 102
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells. 100
8-Isoprostane in exhaled breath condensate (EBC)and excercise-induced bronchoconstriction in asthmatic children and adolescents 98
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 97
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 97
Aging increases amyloid beta-peptide-induced 8-iso-prostaglandin F2alpha release from rat brain. 96
Cyclooxygenase-1, but not -2, is upregulated in NB4 leukemic cells and human primary promyelocytic blasts during neutrophil granulocytic differentiation and contributes to maturation. 96
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 95
Chromatin derived acid peptides inhibit dopamine and norepinephrine release in the hypothalamus. 93
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 92
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 92
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 91
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 91
Problemi di metodologia per la individuazione del rischio tossicologico. Consiglio Nazionale delle Ricerche 90
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. 88
Insulin resistance as a determinant of platelet activation in obese women. 88
Effect of CART peptide-(55-102), leptin and orexin-B on hypothalamicserotonin release. 87
Anterior pituitary cell production of 8-iso-prostaglandin F2alpha. 87
Tachykinin-eicosanoid crosstalk in airway inflammation 85
Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X 85
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 85
Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins. 84
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. 83
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 83
Increased exhaled 8-isoprostane in childhood asthma. 82
Measurement of 8-isoprostane in exhaled breath condensate. 82
Determinants of platelet activation in Alzheimer's disease 82
Soluble RAGE in type 2 diabetes: association with oxidative stress. 81
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 81
Platelet Activation and Lipid Peroxidation in Patients With Acute Ischemic Stroke. 80
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 80
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 80
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 79
Determinants of platelet activation in hypertensives with microalbuminuria. 79
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. 78
Differential Expression and Regulation of Cyclooxygenase Isozymes in Thymic Stromal Cells. 78
Immunological characterization uf urinary 8-epi-prostaglandin f2alfa excretion in man 77
Acute effects of air pollution on pulmonary function, airway inflammation, and oxidative stress in asthmatic children. 77
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 77
Effects of anthracyclines on hypothalamic dopamine release. 76
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 76
Association between PAI-1 and Oxidative Stress in Android Obesity 76
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 76
Role of Platelet Activation in Dementia 75
Induced sputum, exhaled breath condensate and nasal lavage fluid in electroplating workers exposed to chromium 74
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 74
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 74
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 74
Increased thromboxane biosynthesis in essential thrombocythemia 73
Modulation of the expression and activity of cyclooxygenases in normal and accelerated erytrhopoiesis. 73
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 73
Exhaled 8-Isoprostane as an In Vivo Biomarker of Lung Oxidative Stress in Patients with COPD and Healthy Smokers 72
Effect of gherlin and amylin on hypothalamic dopamine, norepinephrine and serotonin release. 72
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 72
Increased macrothrombocytopenia with distinctive platelet ultrastructural and functional features 71
Soluble CD40L as an indicator of platelet Activation in Heart Failure 71
Soluble CD40L in Mediterranean Spotted Fever: Relation to oxidative stress and platelet activation. 71
In vivo formation of 8-epi-prostaglandin F2alpha in increased in hypercholesterolemia. An aspirin-insensitive amplification mechanism of platelet activation (pubbl su Suppl Thromb Haemostas) 70
Identification of 8-iso-prostaglandin (PG) F2alfa in rat brain neuronal endings: a possible marker of membrane phospholipid peroxidation. 70
Validation of 8-isoprostane and prostaglandin E2 measurements in exhaled breath condensate. 70
Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzima-A inhibitor sinvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E. 70
Platelet Activation Markers in Patients with Peripheral Arterial Disease. A Prospective Comparison of Different Platelet Function Tests 70
Effects of montelukast treatment and withhdrawal on fractional exhaled nitric oxide and lung function in children with asthma 69
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the “Low-HDL” Phenotype 69
Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma. 68
Validation of leukotriene B4 measurements in exhaled breath condensate. 68
Anaphylaxis increases 8-iso-PGF2alpha release from guinea-pig lung in vitro 68
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control 68
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 68
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide 67
Tachykinin-eicosanoid crosstalk in airway inflammation 67
Insulin resistance as a determinant of platelet activation in obese women 67
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 67
Effects of cocaine- and amphetamine-regulated transcript peptide, leptin and orexins on hypothalamic serotonin release. 66
Insulin resistance and platelet activation in obese women 66
Thromboxane-dependent CD40L release in type 2 diabetes mellitus 66
Platelet activation in obese women: role of inflammation and oxidant stress. 65
Drugs, prostaglandins, and renal function. 65
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 65
In vivo formation of 8-iso-prostaglandin F2a and aspirin-insensitive thromboxane biosynthesis in unstable angina 64
Inherited Macrothrombocytopenia with Distinctive Platelet Ultrastructural and Functional Features 64
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 62
Determinants of Platelet Activation in Heart Failure. 62
Insulin resistance as a determinant of platelet activation in obese women 62
Signaling pathways involved in lipopolysaccharide stimulation of prostaglandin production by rat hypothalamic astroglial cells 61
Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis. 61
Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. 61
TNF-related apoptosis-inducing ligand (TRAIL) up-regulates cyclooxygenase (COX)-1 activity and PGE2 production in cells of the myeloid lineage. 61
Effects of atorvastatin and rosuvastatin on throboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 61
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 61
Determinants of Platelet Activation in Heart Failure. 61
Totale 7.929
Categoria #
all - tutte 41.178
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.178


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020183 0 0 0 0 0 0 0 0 0 0 175 8
2020/2021872 145 6 146 0 91 198 2 7 85 151 8 33
2021/2022598 17 7 4 118 71 9 11 43 45 11 78 184
2022/20231.930 159 197 126 222 189 447 115 134 233 19 39 50
2023/2024801 62 33 60 22 48 256 216 25 2 7 9 61
2024/20251.751 149 524 484 28 19 55 20 91 174 64 143 0
Totale 10.277